Your browser doesn't support javascript.
loading
Response to: 'Withdrawal of low-dose prednisone in inactive SLE patients: is there another alternative?' by Sabio.
Mathian, Alexis; Pha, Micheline; Amoura, Zahir.
Afiliação
  • Mathian A; Sorbonne Université, Assistance Publique-Hôpitaux de Paris, Groupement Hospitalier Pitié-Salpêtrière, French National Referral Center for Systemic Lupus Erythematosus, Antiphospholipid Antibody Syndrome and Other Autoimmune Disorders, Service de Médecine Interne 2, Institut E3M, Inserm UMRS, Centre d'Immunologie et des Maladies Infectieuses (CIMI-Paris), Paris, France alexis.mathian@psl.aphp.fr.
  • Pha M; Sorbonne Université, Assistance Publique-Hôpitaux de Paris, Groupement Hospitalier Pitié-Salpêtrière, French National Referral Center for Systemic Lupus Erythematosus, Antiphospholipid Antibody Syndrome and Other Autoimmune Disorders, Service de Médecine Interne 2, Institut E3M, Inserm UMRS, Centre d'Immunologie et des Maladies Infectieuses (CIMI-Paris), Paris, France.
  • Amoura Z; Sorbonne Université, Assistance Publique-Hôpitaux de Paris, Groupement Hospitalier Pitié-Salpêtrière, French National Referral Center for Systemic Lupus Erythematosus, Antiphospholipid Antibody Syndrome and Other Autoimmune Disorders, Service de Médecine Interne 2, Institut E3M, Inserm UMRS, Centre d'Immunologie et des Maladies Infectieuses (CIMI-Paris), Paris, France.
Ann Rheum Dis ; 81(4): e58, 2022 04.
Article em En | MEDLINE | ID: mdl-32381565

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Glucocorticoides / Lúpus Eritematoso Sistêmico Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Glucocorticoides / Lúpus Eritematoso Sistêmico Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article